drugset / Trial / NCT01969682

A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

NCT01969682 ↗

Phase 1 Withdrawn AbbVie Genentech, Inc. · collab
NaSingle-groupOpen-labelBasic science

Summary

This is an open-label multicenter, study to assess the pharmacokinetic interaction of rifampin with ABT-199 in up to 12 subjects with relapsed or refractory non-Hodgkin's lymphoma.

Timeline

Start
2014-04
Primary completion
2014-05
Completion
2014-05

Outcome

Outcome not reported

Stopped: “This study will be conducted in healthy volunteer subjects.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifampicin Small molecule — —
Subject Venetoclax Small molecule — —

Indications